Aehr Test Systems (NASDAQ:AEHR) Director Howard Slayen Sells 5,700 Shares of Stock

Aehr Test Systems (NASDAQ:AEHR) Director Howard Slayen sold 5,700 shares of the stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $133.03, for a total value of $758,271.00. Following the transaction, the director owned 140,667 shares in the company, valued at $18,712,931.01. This trade represents a 3.89% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Aehr Test Systems Stock Performance

NASDAQ:AEHR traded up $10.76 during mid-day trading on Friday, reaching $134.06. The stock had a trading volume of 3,300,655 shares, compared to its average volume of 2,436,568. The stock has a market capitalization of $4.37 billion, a P/E ratio of -558.56 and a beta of 3.10. The firm has a 50 day moving average price of $92.12 and a two-hundred day moving average price of $71.00. Aehr Test Systems has a one year low of $16.38 and a one year high of $147.40.

More Aehr Test Systems News

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Jefferies initiated coverage with a bullish view, helping drive renewed investor interest. The analyst reportedly described the price target as conservative and identified additional potential catalysts that were not included in the model. Jefferies Initiates Coverage on Aehr Test Systems
• Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat business supports demand for the company’s FOX systems and strengthens its position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
• Positive Sentiment: Recent company updates pointed to record quarterly bookings of $60.7 million, a backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide revenue visibility and support the investment case tied to rising AI-chip testing demand. Aehr AI Order and WLBI Opportunity
• Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu will meet investors at the Needham Virtual Semiconductor and SemiCap 1×1 Conference on August 19. The event could provide further commentary on backlog conversion and fiscal 2027 execution, but no new financial information was announced. Aehr to Participate in Needham Conference
• Negative Sentiment: Several insiders sold shares after AEHR’s sharp rally. The transactions included the CEO’s sale of 40,000 shares for about $5.2 million, the COO’s sale of 15,000 shares for roughly $2.0 million, and additional director and executive sales. Although insiders retained sizable positions—and the CEO sale came from a trust—such activity may signal profit-taking and add selling pressure. Aehr CEO Share Sale
• Negative Sentiment: One analyst began coverage on a bearish note, highlighting the risk that expectations have become difficult to meet after the stock’s extraordinary advance. AEHR’s elevated valuation and dependence on continued AI order growth leave it vulnerable if bookings, backlog conversion or execution disappoints. Bearish Analyst Initiation

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the stock. Craig Hallum reaffirmed a “buy” rating and issued a $125.00 price objective on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Jefferies Financial Group began coverage on shares of Aehr Test Systems in a research report on Thursday. They issued a “buy” rating and a $175.00 target price on the stock. Wall Street Zen upgraded shares of Aehr Test Systems from a “sell” rating to a “hold” rating in a research report on Saturday, July 18th. Lake Street Capital reaffirmed a “buy” rating and set a $110.00 price objective on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Finally, Weiss Ratings downgraded Aehr Test Systems from a “sell (d)” rating to a “sell (e+)” rating in a report on Wednesday, July 29th. Two research analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $136.67.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in AEHR. Advocate Investing Services LLC purchased a new position in shares of Aehr Test Systems in the second quarter worth $26,000. Compagnie Lombard Odier SCmA purchased a new position in shares of Aehr Test Systems in the second quarter valued at about $34,000. KBC Group NV purchased a new position in shares of Aehr Test Systems in the first quarter valued at about $30,000. Sunbelt Securities Inc. bought a new position in shares of Aehr Test Systems during the third quarter valued at about $27,000. Finally, Tema ETFs LLC purchased a new stake in shares of Aehr Test Systems during the second quarter worth about $89,000. Institutional investors own 69.69% of the company’s stock.

Aehr Test Systems Company Profile

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.